• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Effect of COVID-19 vaccination on the incidence, lethality and mortality of pregnant and postpartum women

tetano

Editor, Senior Moderator
PLoS One


. 2025 Jul 8;20(7):e0327207.
doi: 10.1371/journal.pone.0327207. eCollection 2025. Effect of COVID-19 vaccination on the incidence, lethality and mortality of pregnant and postpartum women

Marcela de Andrade Pereira Silva[SUP] 1 [/SUP], Fernando Castilho Pelloso[SUP] 2 [/SUP], Maria Dalva de Barros Carvalho[SUP] 1 [/SUP], Rosana Rosseto de Oliveira[SUP] 3 [/SUP], Constanza Pujals[SUP] 1 [/SUP], Stéfane Lele Rossoni[SUP] 1 [/SUP], Natan Nascimento de Oliveira[SUP] 3 [/SUP], Mirella Machado Ortiz Modesto[SUP] 3 [/SUP], Deise Helena Pelloso Borghesan[SUP] 4 [/SUP], Ana Carolina Jacinto Alarcão[SUP] 5 [/SUP], Vlaudimir Dias Marques[SUP] 6 [/SUP], Marcia Edilaine Lopes Consolaro[SUP] 7 [/SUP], Camila Wohlenberg Camparoto[SUP] 1 [/SUP], Helena Fiats Ribeiro[SUP] 1 [/SUP], Sandra Marisa Pelloso[SUP] 1 [/SUP]



Affiliations
Abstract

Objectives: To analyze the incidence of Severe Acute Respiratory Syndrome (SARS), lethality and mortality of Brazilian pregnant and postpartum women infected with SARS-CoV-2, before and after vaccination against Covid-19.
Methods: This is an ecological study of time series, carried out with secondary data from the Brazilian Ministry of Health, from March 2020 to April 2024. Slopes and trend changes in the time series were identified by Mann-Kendall and generalized fluctuation tests, respectively. The series was modeled using Generalized Additive Models with interaction between time and start of vaccination. A Pearson correlation was used between the number of accumulated doses and the incidence, lethality and mortality rates, in addition to comparing the average rates before and after the vaccination peak of the first dose using ANOVA.
Results: Significant temporal variations were observed in the incidence rates of SARS, lethality and mortality in pregnant and postpartum women with SARS-CoV-2, before and after vaccination against Covid-19 in Brazil, with a significant decreasing trend after the start of vaccination. It was observed that time alone did not show a significant effect on the reduction of lethality and mortality rates, which occurred only when there was an interaction effect between time and the start of vaccination. The accumulated doses of the vaccine correlated with the decrease in the analyzed rates, which explained 39.18% of variation in the incidence rate, 43.34% in the lethality rate, and 34.81% in the mortality rate. The monthly averages of the incidence, lethality, and mortality rates before and after vaccination reduced significantly.
Conclusions: The findings of this study indicate that vaccination against Covid-19 in Brazilian pregnant and postpartum women had a positive effect on reducing the incidence of SARS by SARS-CoV-2, lethality and mortality rates in the obstetric population.


 
Back
Top Bottom